158 related articles for article (PubMed ID: 25337256)
1. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
[TBL] [Abstract][Full Text] [Related]
2. Comments on Bu et al. "P16(INK₄a) overexpression and survival in osteosarcoma patients: a meta analysis".
Yan MM; Ni JD
Int J Clin Exp Pathol; 2015; 8(6):7617-8. PubMed ID: 26261680
[TBL] [Abstract][Full Text] [Related]
3. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.
Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P
Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803
[TBL] [Abstract][Full Text] [Related]
4. Comments on the article of Bu, et al entitled "P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis".
Liu F; Zhou D; Zhang Q; Wang B
Int J Clin Exp Pathol; 2015; 8(3):3384-5. PubMed ID: 26045875
[No Abstract] [Full Text] [Related]
5. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p16
Lin G; Lou Y
Indian J Cancer; 2017; 54(3):580-583. PubMed ID: 29798963
[TBL] [Abstract][Full Text] [Related]
7. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
8. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p16 INK4a alteration for Ewing sarcoma: a meta-analysis.
Honoki K; Stojanovski E; McEvoy M; Fujii H; Tsujiuchi T; Kido A; Takakura Y; Attia J
Cancer; 2007 Sep; 110(6):1351-60. PubMed ID: 17661343
[TBL] [Abstract][Full Text] [Related]
11. P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA.
Tang Y; Yang C; Guo Z; Fu Y; Yu X; Liu B; Zhou H; Wang J; Li W; Pang Q
Medicine (Baltimore); 2017 May; 96(19):e6714. PubMed ID: 28489748
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of overexpressed p16(INK4A) in esophageal squamous cell carcinoma: a meta-analysis.
Wang L; Li J; Yu X; Zhang Z; Pang L; Li S; Hou J; Li F
Biomark Med; 2016 May; 10(5):537-46. PubMed ID: 27071776
[TBL] [Abstract][Full Text] [Related]
13. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
[TBL] [Abstract][Full Text] [Related]
15. Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas.
Maitra A; Roberts H; Weinberg AG; Geradts J
Int J Cancer; 2001 Jan; 95(1):34-8. PubMed ID: 11241308
[TBL] [Abstract][Full Text] [Related]
16. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Ragazzini P; Sollazzo MR; Merli M; Asp J; Magagnoli G; Balladelli A; Bertoni F; Picci P
Int J Cancer; 1999 Oct; 84(5):489-93. PubMed ID: 10502725
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
Pare R; Shin JS; Lee CS
Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of HPV DNA and p16
Urbute A; Rasmussen CL; Belmonte F; Obermueller T; Prigge ES; Arbyn M; Verdoodt F; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):703-710. PubMed ID: 32051192
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of CDKN2A/p16
Lorenzo-Pouso AI; Caponio VCA; Vieira E Silva FF; Pérez-Jardón A; Álvarez-Calderón-Iglesias Ó; Gándara-Vila P; Pannone G; Pérez-Sayáns M
Pathol Res Pract; 2023 Aug; 248():154656. PubMed ID: 37406376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]